Question

You are analyzing a protein that you believe affects endocytosis, but you are not sure which...

You are analyzing a protein that you believe affects endocytosis, but you are not sure which stage. You create cells with your gene of interest mutated in the genome, and a tet-off system driving a wild-type (WT) copy of your gene (tet-off allows a specific gene to be turned off by adding a tetracycline family drug). After confirming that the system works, you culture the cells with and without tetracycline and in the presence of very high levels of EGF. You then use a gold-labelled antibody to the EGFR receptor and electron microscopy to view localization during endocytosis. Assume that your protein is essential for multivesicular body formation. Where would EGFR be located in the late endosome with and without tetracycline?

0 0
Add a comment Improve this question Transcribed image text
Answer #1

During formation of multi vesicular body ( MVB) formation, early endosome pinched off and contain receptor along with cargo molecules in to late endosomes. This late endosomes is also known as miltivesicular body pathway. So in case of with out tetracyclin, protein resposible fir MVB formation will function normally and lastly EGFR will be located in to late endosomes fused with lysosome.

In presence of tetracyclin-- deletion of the particular gene which involve in MVB formation, so the EGFR will be present in early endosome and gold particles staining will be present in early endosome.

Explanation-

In multivesicular body (MVB) pathway, as ligand ( EGFR) binds to its receptor leads to endocytosed of surface proteins and ligands. After endocytosis receptor and ligand are delivered into the endosomal system. During endocytosis some receptor recycle back to the plasma membrane for example Tfr through recycling endosomes. While cargo proteins destined to lysosome for degradation such as EGFR, . After enter in to the cell , first it present in early endosome. Lster they are sorted into internal lumenal vesicles of MVBs ( late endosomes ) . And lastly these Mature MVBs fuse with the lysosome and these internal vesicles are delivered to the lysosomal lumen where cargo and vesicles both are degraded by the lysosomal enzymes.

Add a comment
Know the answer?
Add Answer to:
You are analyzing a protein that you believe affects endocytosis, but you are not sure which...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • Pls give short answers. Thank you Q5 EGF pathway 23 Points A EGF EGFR GRB2 SOS...

    Pls give short answers. Thank you Q5 EGF pathway 23 Points A EGF EGFR GRB2 SOS KRAS Active RAS KRAS GOP GDP GTP RAF РІЗК MEK АКТ) ERK Growth and Suppression Proliferation of Apoptosis Shown is the EGF signaling pathway. This is a pathway that normally promotes growth during development, and inhibits apoptosis (or programmed cell death). This pathway is also involved in cancer. Epidermal growth factor (EGF) binds to its receptor (EGFR). This binding activates the protein KRAS, which...

  • Question 36 1 pts 36. You have a population of mammalian cells growing in media containing...

    Question 36 1 pts 36. You have a population of mammalian cells growing in media containing enough growth factors. Which of the following graphs corresponds to these cells when their DNA content is analyzed 24 hours after they are induced to express high levels of a mutant form of Rb protein that cannot be phosphorylated? (Note: this cell line has its cell cycle around 22 hours) Control cells #1 #2 #3 #4 #5 #6 Cell number JAN ul. 2 2...

  • In-Class Activity #12, Protein Tratlicking Worksheet 1. You are interested in four different proteins in a...

    In-Class Activity #12, Protein Tratlicking Worksheet 1. You are interested in four different proteins in a yeast cell: • protein 1 is a cytosolic protein protein 2 is a secreted protein • protein 3 is a nuclear protein protein 4 is a cell surface membrane protein with N-terminal end in extra-cellular space. a. You plan to study how the proteins are localized to their specific destination by creating the following mutations in the genes encoding proteins 1-4. Indicate how the...

  • Name 2ors L! You are inte finding protein are interested in understanding how Top5 expression is...

    Name 2ors L! You are inte finding protein are interested in understanding how Top5 expression is regulated. Top5 is a microtubule protein. You study a cell line where Top5 expression is controlled by a signal, Ligl. When hinds to and activates the membrane bound recentor it activates the Ras protein, which activates atein kinase called PKF, which then phosphorylates Grp4 on T224. Grp4 is a gene regulatory Wotein that can only enter the nucleus when phosphorylated: Thos is not expressed...

  • 32. Study the signaling pathway illustrated below, which involves two different receptors. Assume that a protein...

    32. Study the signaling pathway illustrated below, which involves two different receptors. Assume that a protein is active only when it is activated, but not inhibited, by its upstream signaling molecules. Activation and inhibition are indicated by normal and blunt arrows, respectively. Assume that the transcription regulator can be activated by either the binding protein or the kinase that are immediately upstream of the transcription factor. Under which of the following conditions will the expression of target:gene "X" be induced?...

  • Please answer all the questions (1-6) Thank you. I’ll be sure to leave you a like...

    Please answer all the questions (1-6) Thank you. I’ll be sure to leave you a like :) check Your Understanding 5. How does the mutated CFTR protein contribute to What is the difference between genetic engineering and cloning a. Genetic engineering is governed by an international cystic fibrosis? a. The mutation prevents the channel protein from moving chloride across the membrane, resulting in a thick, sticky mucus ethics committee. Cloning does not have any formal ethics oversight. b. The mutation...

  • Which of the following statements best describes the difference between a benign and malignant tumor?_____ (type...

    Which of the following statements best describes the difference between a benign and malignant tumor?_____ (type 1, 2, or 3 in the blank) 1. benign tumors rarely interfere with organ function but malignant tumors often impair and spread to other organs. 2. benign tumors are produced from unregulated cell growth but malignant tumors are regulated 3. benign tumors metastasize but malignant tumors do not Which of the following statements best describes metastasis? ____ 1. metastasis is unregulated growth of cells...

  • 1) You have two human liver cells (A and B) and you hypothesize that the insulin...

    1) You have two human liver cells (A and B) and you hypothesize that the insulin receptor gene in Cell A has a mutation in exon 1 and Cell B contains the wild type sequence.  You extract genomic DNA from each of the cells.  Of the following, what would be the most efficient (quick, precise and relatively cheap) way to test your hypothesis. a. Isolate protein from both cells, purify the insulin receptor, and determine the amino acid content. b. Sequence the...

  • can someone explain how to answer this with reasons why 30-45 mins after estrogen addition: Acchyiase...

    can someone explain how to answer this with reasons why 30-45 mins after estrogen addition: Acchyiase (HAT, odde auhye 60-90 mins after estrogen addition: Reauitment ef Poy to open 7. T identify the Gene X DNA element responsible for regulation by a Growth Fagor, you perform a linker scanning experiment in which you mutate 10 bp Tegions centered around positions -205 to-5 in the Gene X promoter/promoter- proximal region (wt wild-type promoter). The promoter variants were tested for their ability...

  • . Gleevec (Imatinib) inhibits protein kinase BCR-ABL, which is constitutively active in patients with Chronic Myelogenous...

    . Gleevec (Imatinib) inhibits protein kinase BCR-ABL, which is constitutively active in patients with Chronic Myelogenous Leukemia (CML). The structure of Gleevec is shown below: a) Based on our discussion in lecture and the structure above, explain how the “lead” compound structure for Gleevec was designed and how it led to the development a compound that could bind ABL with higher affinity than ATP. b) Using a broad kinase inhibition assay, you discover that Gleevec inhibits another tyrosine kinase called...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT